8 research outputs found
Anti-mitotic and anti-proliferation potentials of aqueous and methanolic extracts of fermented Citrullus vulgaris (ogiri-egusi) seeds
There is a growing scientific evidence of the health-enhancing benefits of fermented food and beverages, especially in cancer prevention and treatment. Ogiri-egusi is an indigenously fermented condiment consumed in some West African countries, and prepared mainly from natural fermentation of melon (Citrullus vulgaris) seeds. The condiment has been previously reported to possess anti-oxidative and anti hyperlipid emic properties. In this study, different concentrations of ogiri-egusi extracts were exposed to actively dividing cells from Allium cepa meristematic roots and Saccharomyces cerevisiae for the antimitotic and antiproliferative investigations, respectively. There was a statistically significant reduction in mitotic activities of the treated A. cepa meristematic cells compared to the untreated cells. The mitotic index (MI) of the untreated cells was 28.38 ± 4.58. At a concentration of 1.0 mg/ml, the extracts induced a reduction in the MI to 6.02 ± 2.74 and 4.94 ± 0.61 in the aqueous and methanolic extracts- treated cells, respectively. Some chromosomal aberrations were also observed. In addition, proliferation in yeast cells was significantly inhibited at all the concentrations of the aqueous extract examined as well as at the highest concentration of the methanolic extract. These results provide useful insights to the cytotoxic and genotoxic effects of fermented Citrullus vulgaris.
Keywords: Fermented Citrullus vulgaris, Allium cepa, antiproliferation, cytotoxicity, genotoxicit
EVALUATION OF THE EFFECT OF SPATHODEA CAMPANULATA FLOWER BUD EXUDATE ON CATARACTOGENESIS IN RAT LENSES
Background: The flower bud exudates of Spathodea campanulata is commonly used as a local eye drop in Nigeria and is anecdotally claimed to improve vision. This study evaluated the anti-cataract activity of Spathodea campanulata (SPCM) flower bud exudates against cataractogenesis using rat lenses. This was done with a view to providing empirical scientific support for the use of the exudates from SPCM in the treatment and management of certain eye disorders.
Materials and Methods: Fifty (50) rat lenses were used in this study, i.e. five groups of ten (10) lenses per group. Lenses were incubated in artificial aqueous humor (Normal control) with simultaneous incubation in 30 mM galactose (Untreated cataract). Co-incubation with captopril (Captopril treated cataract); 0.1 mg/ml of the exudate (Exudate treated cataract - Low dose) and 0.2 mg/ml of exudate (Exudate treated cataract- High dose) constituted the study groups. After 72 hr of incubation, lenses were observed for cataract and the preventive potential of the exudate against cataractogenesis was evaluated through the determination of the levels of anti-oxidant parameters such as total protein (TP), glutathione (GSH), malondialdehyde (MDA) and activities of superoxide dismutase (SOD) and catalase (CAT) were evaluated in the lens homogenates.
Results: Photographic evaluation of the lenses showed the development of cataract in the untreated cataract group while opacification was retarded in higher dose exudate-treated and captopril treated lenses. Significant decrease in the levels of GSH and total protein, reduction in SOD and CAT activities as well as increase in MDA content were observed in cataractous lenses when compared with the normal control. SPCM displayed a dose-related anti-cataract activity. Captopril showed comparable anti-cataract potential to (0.2 mg/ml) SPCM. GSH, SOD and CAT activity in captopril treated cataract lenses increased to 75.55%, 64.08% and 72.45% of the normal control values respectively. In (0.2 mg/ml) exudate treated cataract lenses; GSH, SOD and CAT activity increased to 57.7%, 76.69% and 80.61% respectively.
Conclusion: The study concluded that exudate of SPCM elicited its anti-cataract potential through its anti-oxidant activities
Modulation of Blood Coagulation and Hematological Parameters by Crassocephalum crepidioides Leaf Methanol Extract and Fractions in STZ-Induced Diabetes in the Rat
Diabetes affects the homeostasis of the circulatory system. Crassocephalum crepidioides Benth S. Moore (Asteraceae) is an edible plant locally used in the treatment of wounds, stomach ulcer, and skin-related conditions in Africa and some other parts of the world. This study investigated the effects of C. crepidioides leaf methanol extract and fractions on blood coagulation profile of diabetic Wistar rats. The effect of 100 mg/kg body weight of the methanol extract and partitioned fractions of C. crepidioides on blood coagulation profile of STZ-induced diabetic rats were initially evaluated, while graded concentrations (50–200 mg/kg body weight) of the aqueous and hexane fractions were further tested in diabetic rats against standard drugs aspirin (anticoagulant) and metformin (antidiabetic). Rats were allocated into groups (n = 6) and administration was done orally, once daily for 2 weeks. The methanol extract and fractions of C. crepidioides at concentrations of 50, 100, and 200 mg/kg significantly prolonged the bleeding (58–200%), clotting (65–133%), prothrombin (176–441%), and activated partial thromboplastin (209–518%) times in diabetic rats compared to the control rats (LD50 ≥ 5000 mg/kg). Highest prolongation effects were recorded in the diabetic group treated with 100 mg/kg body weight of the hexane fraction. Plasma calcium concentration and platelet counts of C. crepidioides treated diabetic rats were significantly (P<0.05) reduced compared to diabetic control rats, while the red blood cells (RBC), hemoglobin concentration, and packed cell volume (PCV) were significantly increased. This study showed that C. crepidioides possess anticoagulant and antianemic activities. The leaves can thus be a potential source of novel anticoagulant and nutraceutical for management of the thrombotic disorder in diabetes and other diseased states